Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase NA 3Phase 1/2 2Phase 4 1Phase 3 1

Status

Completed 4Unknown 3Withdrawn 1Terminated 1Recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 3

Conditions

Carcinoma, Renal Cell 2Kidney Neoplasms 1

Interventions

Exercise 59Radiotherapy 49Blood Specimen Collection 45Radiosurgery 37Drug Therapy 35Standard of Care 32Surgical Procedures, Operative 30Magnetic Resonance Spectroscopy 26Laparoscopy 24Cisplatin 24Cyclophosphamide 23Control Groups 23Biopsy 23Acupuncture Therapy 23Magnetic Resonance Imaging 20Saline Solution 19Radiofrequency Ablation 19Endoscopic Mucosal Resection 19camrelizumab 16Surveys and Questionnaires 16Propofol 16Metformin 16Cytarabine 16anlotinib 15Preoperative Exercise 15Injections 15Fluorouracil 15Radiotherapy, Intensity-Modulated 14Neoadjuvant Therapy 14Early Intervention, Educational 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase NA × Unknown × pazopanib × Clear all
NCT05816642 2023-04-18

Application Circulating Tumor DNA Dynamic Monitoring in Clinical Treatment of Metastatic Renal Cell Carcinoma

RenJi Hospital

Phase NA Unknown
500 enrolled
Genitourinary

Carcinoma, Renal Cell

NCT03571438 2020-01-18

COMBOREIN

University Hospital, Grenoble

Phase NA Unknown
100 enrolled
Genitourinary

Kidney Neoplasms

NCT02208128 2014-08-04

MORE

Heidelberg University

Phase NA Unknown
4 enrolled
Genitourinary

Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡